This study is in progress, not accepting new patients
Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Incyte Corporation
- ID
- NCT04530344
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Last Updated